查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
無引線心臟節律器全球市場規模、佔有率、產業趨勢分析報告：2023-2030 年依類型、最終用途、地區分類的展望與預測
市場調查報告書
商品編碼
1384882

無引線心臟節律器全球市場規模、佔有率、產業趨勢分析報告：2023-2030 年依類型、最終用途、地區分類的展望與預測

Global Leadless Pacemakers Market Size, Share & Industry Trends Analysis Report By Type (Micra Transcatheter Pacing System, and Others), By End-use (Hospitals, and Outpatient Facilities), By Regional Outlook and Forecast, 2023 - 2030
出版日期: | 出版商: KBV Research | 英文 199 Pages | 訂單完成後即時交付

價格

到 2030 年，無引線心臟節律器市場規模預計將達到 8.277 億美元，預測期內市場CAGR率為 15.2%。

根據 KBV Cardinal 矩陣中發布的分析，美敦力公司 (Medtronic PLC) 和雅培實驗室 (Abbott Laboratories) 是市場上的領先參與者。波士頓科學公司、Integer Holdings Corporation 和 Terumo Corporation 等公司是該市場的主要創新者。 2023 年 9 月，波士頓科學公司宣布收購Lillyvant Medsystems，這是一家專門從事脊椎疼痛治療的私人醫療設備公司。此次收購將 Relievant Medsystems 經臨床驗證的技術與 Boston Scientific 的策略相結合，為需要個人化醫療的個人擴大了治療選擇。

COVID-19 的影響

疫情期間，許多醫院和醫療機構推遲或取消了擇期手術，以節省資源並降低病毒傳播的風險。因此，無引線起搏器植入術已經減少，因為它通常被認為是一種選擇性的、非緊急的手術。包括無引線起搏器在內的醫療設備的全球供應鏈因製造和運輸的封鎖和限制而受到干擾。這有可能延遲醫療設備的供應並阻止患者獲得這些尖端技術。醫療保健提供者已指示資源和工作人員應對 COVID-19 病例激增的情況。這種轉移到非新冠疫情衛生服務的注意力和資源影響了無引線起搏器的普及和植入。

市場成長要素

微創手術需求不斷成長

微創手術的發展減少了導線放置和手術切口的需要，降低了手術風險並提高了患者的舒適度。這種侵入性的減少不僅提高了病患的安全性，也縮短了復原時間。接受無引線心律調節器植入的患 者住院時間較短，術後不適也較少。這種快速康復使患者能夠快速恢復日常生活和活動。這些程序為獲得醫療設施可能受到限制的偏遠和農村醫療保健環境開闢了新的可能性。因此，對微創手術的需求迅速增加，推動市場擴張。

心律不整盛行率上升

心律不整盛行率的上升是多種因素的複雜組合，從人口變化到生活方式的選擇，再到醫療保健的進步。高血壓是心律不整的既定危險因子。高血壓會導致心臟結構和電訊號發生變化，增加心律不整的可能性。同樣，糖尿病與心律不整，特別是心房顫動的風險增加有關。此外，心律不整的盛行率並不限於特定年齡層，而是影響不同階層的個體。所有年齡層患有心律不整的患者，從老年人到年輕人，都可以從這些設備中受益。因此，心律不整的日益普及正在推動對無引線起搏器的需求。

市場抑制因素

監管和報銷課題

監管課題，例如醫療設備複雜且漫長的核准流程，可能會大大推遲無引線起搏器的推出。監管機構要求對安全性和有效性進行徹底評估，導致產品認證的時間更長。監管核准的延遲不僅使患者無法獲得先進的醫療解決方案，還會增加製造商的上市時間，影響他們提供尖端設備的能力。這些設備的經濟負擔可能會阻止醫療保健提供者和患者選擇無引線起搏器作為起搏解決方案，儘管它們具有潛在的好處。這種經濟負擔可能會阻止人們選擇這些設備，特別是當有更具成本效益的替代療法可用時。所有這些因素都會阻礙市場的成長。

依類型分類的展望

依類型分類，市場可分為 Micra 經導管起搏系統和其他系統。其他區隔市場在2022年也獲得了可觀的市場成長。無引線心律調節器，包括 NanoStim 和 WiSE CRT 系統等設備，與傳統引線心律調節器相比具有多種優勢。 Nanostim 非常緊湊，大約有一個大維生素膠囊的大小。這種小尺寸可實現侵入性較小的手術，並實現更謹慎和舒適的植入。 WiSE CRT 系統專為心臟再同步治療（一種心臟衰竭治療方法）而設計。無需傳統起搏導線即可提供心臟再同步的優點。 NanoStim 和 WiSE CRT 系統均具有顯著優勢，包括微創植入、緊湊設計、降低感染風險、美容功效和長電池壽命。

最終用途展望

依最終用途，市場分為醫院和門診病人。 2022 年，醫院業務在市場中佔最大的收益佔有率。醫院可以更有效地分配資源，因為他們不需要專門的手術室或手術團隊專用植入心律調節器。這可以節省成本並為其他重要的醫療程序釋放資源。由於沒有引線離開人體，因此幾乎消除了與引線插入部位相關的感染疾病風險。醫院可以受益於與設備相關的較低感染率。

區域展望

從區域來看，本報告對北美、歐洲、亞太地區和拉丁美洲地區的市場進行了分析。 2022 年，北美市場佔最大的收益佔有率。在北美，對無引線起搏器的需求正在穩定成長。這些因素凸顯了心臟起搏技術的發展以及心律不整治療向更加以患者為中心、侵入性較小且技術先進的選擇的轉變。無引線心律調節器不需要引線，引線容易受到感染疾病。這項功能在北美等感染控制是重中之重的地區受到高度重視。

目錄

第1章 市場範圍和調查方法

  • 市場定義
  • 目的
  • 市場範圍
  • 分割
  • 調查方法

第2章 市場概況

  • 主要亮點

第3章 市場概況

  • 介紹
    • 概述
      • 市場構成和情勢
  • 影響市場的主要因素
    • 市場促進因素
    • 市場抑制因素

第4章 競爭分析-世界

  • KBV Cardinal Matrix
  • 近期全產業策略發展
    • 夥伴關係、協作和協議
    • 產品發布和產品擴展
    • 收購和合併
    • 測試和核准
  • 關鍵成功策略
    • 主要策略
    • 重大策略舉措
  • 波特五力分析

第5章 全球無引線心律調節器市場：依類型

  • 全球 Micra 經導管心律調節系統市場（依地區）
  • 世界其他市場：依地區

第6章 全球市場：依最終用途分類

  • 全球醫院市場：依地區
  • 全球門診設施市場：依地區

第7章 世界市場：依地區

  • 北美市場
  • 歐洲市場
  • 亞太市場
  • 拉丁美洲/中東/非洲市場

第8章 公司簡介

  • Medtronic PLC
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Biotronik SE & Co KG
  • Lepu Medical Technology Co, Ltd
  • Integer Holdings Corporation
  • MicroPort Scientific Corporation
  • OSYPKA AG
  • Terumo Corporation
  • EBR Systems, Inc

第9章 市場成功的必要條件

The Global Leadless Pacemakers Market size is expected to reach $827.7 million by 2030, rising at a market growth of 15.2% CAGR during the forecast period.

European patients and healthcare providers are increasingly valuing minimally invasive procedures. Thus, the European region would register nearly 28% share of the market by 2030. The catheter-based implantation of leadless pacemakers eliminates the need for surgical pockets and leads, reducing pain, scarring, and recovery time. Europe possesses a well-developed healthcare infrastructure with advanced medical facilities and resources. Many outpatient facilities as well as hospitals in this region are equipped to perform leadless pacemaker implantations and provide necessary follow-up care.

The major strategies followed by the market participants are Mergers & Acquisitionas the key developmental strategy to keep pace with the changing demands of end users. For instance, In August, 2022, Medtronic plc completed the acquisition of Affera, Inc., expanding its cardiac ablation portfolio with the addition of a groundbreaking cardiac mapping and navigation platform, featuring a fully integrated diagnostic, focal pulsed field, and radiofrequency ablation solution. Moreover, In April, 2023, Abbott Laboratories completed the acquisition of Cardiovascular Systems, Inc. (CSI), a medical device company known for its innovative atherectomy system in the treatment of peripheral and coronary artery disease. This acquisition enhances Abbott's offerings for vascular disease treatment, incorporating CSI's leading atherectomy system, which prepares vessels for angioplasty or stenting to restore blood flow.

Based on the Analysis presented in the KBV Cardinal matrix; Medtronic PLC and Abbott Laboratories are the forerunners in the Market. Companies such as Boston Scientific Corporation, Integer Holdings Corporation and Terumo Corporation are some of the key innovators in the Market. In September, 2023, Boston Scientific Corporation announced the acquisition of Relievant Medsystems, Inc., a privately held medical device company specializing in vertebrogenic pain treatment. This acquisition enables the integration of Relievant Medsystems' clinically backed technology with Boston Scientific's strategies, expanding treatment options for individuals in need of personalized care.

COVID-19 Impact

During the pandemic, many hospitals and healthcare facilities postponed or canceled elective procedures to free up resources and reduce the risk of virus transmission. This led to a decrease in leadless pacemaker implantations, as these procedures are often considered elective and non-urgent. The global supply chain for medical devices, including leadless pacemakers, experienced disruptions due to lockdowns and restrictions on manufacturing and transportation. This led to delays in the availability of devices and potentially impacted patients' access to these advanced technologies. Hospitals and healthcare providers redirected resources and staff to handle the surge of COVID-19 cases. This diversion of attention and resources from non-COVID medical services affected the promotion and implantation of leadless pacemakers.

Market Growth Factors

Growing demand for minimally invasive procedures

The development of minimally invasive procedures has decreased the need for lead placement and surgical incisions, lowering surgical risks and enhancing patient comfort. This reduction in invasiveness has not only translated into enhanced patient safety but also quicker recovery times. Patients undergoing leadless pacemaker implantation experience shorter hospital stays and reduced post-operative discomfort. This quick recovery benefits patients by allowing them to return to their daily routines and activities more swiftly. These procedures have opened up new possibilities for remote and rural healthcare settings, where access to healthcare facilities may be limited. As a result, the rapidly increasing demand for minimally invasive procedures will aid in the expansion of the market.

Rising prevalence of cardiac arrhythmias

The rising prevalence of cardiac arrhythmias is a complex interplay of multiple factors, from demographic changes to lifestyle choices and advances in healthcare. High blood pressure is a well-established risk factor for arrhythmias. It can lead to changes in the heart's structure and electrical signaling, increasing the likelihood of arrhythmias. Similarly, diabetes is associated with an increased risk of arrhythmias, particularly atrial fibrillation. Furthermore, the prevalence of arrhythmias is not limited to specific age groups; it affects individuals across various demographics. Patients of all ages who experience cardiac arrhythmias, from the elderly to younger individuals, can benefit from these devices. Therefore, the rising prevalence of arrhythmias is boosting the demand for leadless pacemakers.

Market Restraining Factors

Regulatory and reimbursement challenges

Regulatory challenges, such as the complex and lengthy approval process for medical devices, can significantly delay the introduction of leadless pacemakers. Regulatory agencies require thorough evaluations of safety and efficacy, leading to prolonged timeframes for product clearance. Delays in regulatory approval not only hinder patients' access to advanced medical solutions but also increase the time-to-market for manufacturers, impacting their ability to offer cutting-edge devices. The economic burden of these devices can deter both healthcare providers and patients from choosing leadless pacemakers as a pacing solution despite their potential benefits. Such financial burdens may discourage some individuals from opting for these devices, especially if more cost-effective alternatives are available. All these factors may hamper the growth of the market.

Type Outlook

Based on type, the market is bifurcated into micra transcatheter pacing system and others. The other segment procured a considerable growth rate in the market in 2022. Leadless pacemakers, including devices like Nanostim and WiSE CRT System, offer several benefits compared to traditional pacemakers with leads. Nanostim is remarkably compact, similar in size to a large vitamin capsule. This small size allows for a less invasive procedure and results in a more unobtrusive and comfortable implantation. The WiSE CRT System is designed for cardiac resynchronization therapy, a treatment for heart failure. It offers the benefits of cardiac resynchronization without the need for traditional pacing leads. Both Nanostim and the WiSE CRT System provide significant advantages, such as minimally invasive implantation, compact designs, reduced infection risk, cosmetic benefits, and long-lasting battery life.

End-use Outlook

On the basis of end-use, the market is divided into hospitals and outpatient facilities. The hospitals segment acquired the largest revenue share in the market in 2022. Hospitals can efficiently allocate resources, as there is no need for specialized surgical suites or surgical teams dedicated to pacemaker implantations. This can lead to cost savings and the reallocation of resources to other critical medical procedures. With no leads that exit the body, the risk of infections related to lead entry sites is virtually eliminated. Hospitals can benefit from reduced rates of device-related infections.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment witnessed the maximum revenue share in the market in 2022. The demand for leadless pacemakers is steadily increasing in North America due to several factors contributing to their growing adoption in the region. These factors highlight the evolving landscape of cardiac pacing technology and the shift towards more patient-centric, minimally invasive, and technologically advanced options for treating cardiac arrhythmias. Leadless pacemakers eliminate the need for leads that can be susceptible to infection. In regions like North America, where infection control is a priority, this feature is highly valued.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, Lepu Medical Technology Co., Ltd, Integer Holdings Corporation, MicroPort Scientific Corporation, Osypka AG, Terumo Corporation, and EBR Systems, Inc.

Strategies Deployed in Leadless Pacemakers Market

Partnerships, Collaborations, and Agreements:

Jul-2022: Medtronic plc has formed a strategic partnership with CathWorks, a privately held company headquartered in Kefar Sava, Israel, investing up to $75 million and co-promoting the FFRangio System globally. The agreement included an option for Medtronic to acquire CathWorks based on milestones, with CathWorks having the right to compel the acquisition if Medtronic opts out.

Sep-2021: Terumo Cardiovascular partnered with Etiometry to provide enhanced monitoring insights for adult cardiac surgery patients. This collaboration expanded technologies and enabled the utilization of clinical-decision support tools throughout a patient's hospital stay, offering a more comprehensive view of critical data for improved and informed bedside decisions during the transition from the operating room to the ICU.

Product Launches and Product Expansions:

Feb-2022: Abbott Laboratories has revealed the world's first patient implants of a dual-chamber leadless pacemaker system in its AVEIR DR i2i™ pivotal clinical study. The implant of Abbott's investigational Aveir dual-chamber leadless pacemaker marks a notable technological milestone in leadless pacing, representing the first such occurrence globally within the pivotal trial.

Jan-2022: Medtronic received regulatory approval and launched the Micra AV Transcatheter Pacing System in Japan. This pacemaker was designed to treat patients with AV block, addressing impaired electrical signals between the heart's chambers. The Micra TPS is the world's first leadless pacemaker, with the initial version (Micra VR) approved in Japan in 2017 for patients requiring single-chamber pacing.

Jun-2021: Medtronic PLC has introduced the MICRA AV, a pacemaker smaller than conventional ones, offering a leadless and minimally invasive solution for patients with complete heart block. This innovation, following Medtronic's legacy of inventing and disrupting, provides a cosmetically invisible option for those in need.

Acquisition and Mergers:

Sep-2023: Boston Scientific Corporation has announced the acquisition of Relievant Medsystems, Inc., a privately held medical device company specializing in vertebrogenic pain treatment. This acquisition enables the integration of Relievant Medsystems' clinically backed technology with Boston Scientific's strategies, expanding treatment options for individuals in need of personalized care.

Apr-2023: Abbott Laboratories completed the acquisition of Cardiovascular Systems, Inc. (CSI), a medical device company known for its innovative atherectomy system in the treatment of peripheral and coronary artery disease. This acquisition enhances Abbott's offerings for vascular disease treatment, incorporating CSI's leading atherectomy system, which prepares vessels for angioplasty or stenting to restore blood flow.

Aug-2022: Medtronic plc completed the acquisition of Affera, Inc., expanding its cardiac ablation portfolio with the addition of a groundbreaking cardiac mapping and navigation platform, featuring a fully integrated diagnostic, focal pulsed field, and radiofrequency ablation solution.

May-2022: Medtronic PLC completed the acquisition of Intersect ENT, integrating PROPEL and SINUVA into its portfolio. PROPEL implants, maintaining sinus patency and delivering steroids, and SINUVA implants, treating nasal polyps in ethmoid sinus surgery patients, are now part of Medtronic's offerings.

Feb-2022: Boston Scientific has completed the acquisition of Baylis Medical Company Inc. This integration enables Boston Scientific to incorporate Baylis platforms into its existing electrophysiology and structural heart offerings, reinforcing its position in the rapidly growing cardiology markets.

Sep-2021: Boston Scientific Corporation completed the acquisition of Devoro Medical, Inc., a developer of a medical device intended to restore blood flow. Through this acquisition, the WOLF Thrombectomy Platform was integrated into Boston Scientific's products. Additionally, this acquisition provided the physicians with the necessary tools needed for the treatment.

Trials and Approval:

Dec-2022: Biotronik SE & Co. KG has initiated the first patient enrollment in BIO-CONDUCT, an FDA-approved investigational device exemption (IDE) trial. The study examines the use of the BIOTRONIK Solia S pacing lead when implanted in the left bundle branch (LBB) area, a location not currently approved for the Solia S lead.

Dec2021: Boston Scientific Corporation has started the MODULAR ATP clinical trial to assess the mCRM Modular Therapy System, which includes the EMBLEM™ MRI S-ICD System and the EMPOWER™ MPS, aiming to be the first leadless pacemaker capable of delivering bradycardia pacing support and antitachycardia pacing (ATP).

Scope of the Study

Market Segments covered in the Report:

By Type

  • Micra Transcatheter Pacing System
  • Others

By End-use

  • Hospitals
  • Outpatient Facilities

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Medtronic PLC
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Biotronik SE & Co. KG
  • Lepu Medical Technology Co., Ltd
  • Integer Holdings Corporation
  • MicroPort Scientific Corporation
  • Osypka AG
  • Terumo Corporation
  • EBR Systems, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Leadless Pacemakers Market, by Type
    • 1.4.2 Global Leadless Pacemakers Market, by End-use
    • 1.4.3 Global Leadless Pacemakers Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints

Chapter 4. Competition Analysis - Global

  • 4.1 KBV Cardinal Matrix
  • 4.2 Recent Industry Wide Strategic Developments
    • 4.2.1 Partnerships, Collaborations and Agreements
    • 4.2.2 Product Launches and Product Expansions
    • 4.2.3 Acquisition and Mergers
    • 4.2.4 Trials & Approvals
  • 4.3 Top Winning Strategies
    • 4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
    • 4.3.2 Key Strategic Move: (Mergers & Acquisition: 2019, Nov - 2023, Sep) Leading Players
  • 4.4 Porter's Five Forces Analysis

Chapter 5. Global Leadless Pacemakers Market, By Type

  • 5.1 Global Micra Transcatheter Pacing System Market, By Region
  • 5.2 Global Others Market, By Region

Chapter 6. Global Leadless Pacemakers Market, By End-use

  • 6.1 Global Hospitals Market, By Region
  • 6.2 Global Outpatient Facilities Market, By Region

Chapter 7. Global Leadless Pacemakers Market, By Region

  • 7.1 North America Leadless Pacemakers Market
    • 7.1.1 North America Leadless Pacemakers Market, By Type
      • 7.1.1.1 North America Micra Transcatheter Pacing System Market, By Country
      • 7.1.1.2 North America Others Market, By Country
    • 7.1.2 North America Leadless Pacemakers Market, By End-use
      • 7.1.2.1 North America Hospitals Market, By Country
      • 7.1.2.2 North America Outpatient Facilities Market, By Country
    • 7.1.3 North America Leadless Pacemakers Market, By Country
      • 7.1.3.1 US Leadless Pacemakers Market
        • 7.1.3.1.1 US Leadless Pacemakers Market, By Type
        • 7.1.3.1.2 US Leadless Pacemakers Market, By End-use
      • 7.1.3.2 Canada Leadless Pacemakers Market
        • 7.1.3.2.1 Canada Leadless Pacemakers Market, By Type
        • 7.1.3.2.2 Canada Leadless Pacemakers Market, By End-use
      • 7.1.3.3 Mexico Leadless Pacemakers Market
        • 7.1.3.3.1 Mexico Leadless Pacemakers Market, By Type
        • 7.1.3.3.2 Mexico Leadless Pacemakers Market, By End-use
      • 7.1.3.4 Rest of North America Leadless Pacemakers Market
        • 7.1.3.4.1 Rest of North America Leadless Pacemakers Market, By Type
        • 7.1.3.4.2 Rest of North America Leadless Pacemakers Market, By End-use
  • 7.2 Europe Leadless Pacemakers Market
    • 7.2.1 Europe Leadless Pacemakers Market, By Type
      • 7.2.1.1 Europe Micra Transcatheter Pacing System Market, By Country
      • 7.2.1.2 Europe Others Market, By Country
    • 7.2.2 Europe Leadless Pacemakers Market, By End-use
      • 7.2.2.1 Europe Hospitals Market, By Country
      • 7.2.2.2 Europe Outpatient Facilities Market, By Country
    • 7.2.3 Europe Leadless Pacemakers Market, By Country
      • 7.2.3.1 Germany Leadless Pacemakers Market
        • 7.2.3.1.1 Germany Leadless Pacemakers Market, By Type
        • 7.2.3.1.2 Germany Leadless Pacemakers Market, By End-use
      • 7.2.3.2 UK Leadless Pacemakers Market
        • 7.2.3.2.1 UK Leadless Pacemakers Market, By Type
        • 7.2.3.2.2 UK Leadless Pacemakers Market, By End-use
      • 7.2.3.3 France Leadless Pacemakers Market
        • 7.2.3.3.1 France Leadless Pacemakers Market, By Type
        • 7.2.3.3.2 France Leadless Pacemakers Market, By End-use
      • 7.2.3.4 Russia Leadless Pacemakers Market
        • 7.2.3.4.1 Russia Leadless Pacemakers Market, By Type
        • 7.2.3.4.2 Russia Leadless Pacemakers Market, By End-use
      • 7.2.3.5 Spain Leadless Pacemakers Market
        • 7.2.3.5.1 Spain Leadless Pacemakers Market, By Type
        • 7.2.3.5.2 Spain Leadless Pacemakers Market, By End-use
      • 7.2.3.6 Italy Leadless Pacemakers Market
        • 7.2.3.6.1 Italy Leadless Pacemakers Market, By Type
        • 7.2.3.6.2 Italy Leadless Pacemakers Market, By End-use
      • 7.2.3.7 Rest of Europe Leadless Pacemakers Market
        • 7.2.3.7.1 Rest of Europe Leadless Pacemakers Market, By Type
        • 7.2.3.7.2 Rest of Europe Leadless Pacemakers Market, By End-use
  • 7.3 Asia Pacific Leadless Pacemakers Market
    • 7.3.1 Asia Pacific Leadless Pacemakers Market, By Type
      • 7.3.1.1 Asia Pacific Micra Transcatheter Pacing System Market, By Country
      • 7.3.1.2 Asia Pacific Others Market, By Country
    • 7.3.2 Asia Pacific Leadless Pacemakers Market, By End-use
      • 7.3.2.1 Asia Pacific Hospitals Market, By Country
      • 7.3.2.2 Asia Pacific Outpatient Facilities Market, By Country
    • 7.3.3 Asia Pacific Leadless Pacemakers Market, By Country
      • 7.3.3.1 China Leadless Pacemakers Market
        • 7.3.3.1.1 China Leadless Pacemakers Market, By Type
        • 7.3.3.1.2 China Leadless Pacemakers Market, By End-use
      • 7.3.3.2 Japan Leadless Pacemakers Market
        • 7.3.3.2.1 Japan Leadless Pacemakers Market, By Type
        • 7.3.3.2.2 Japan Leadless Pacemakers Market, By End-use
      • 7.3.3.3 India Leadless Pacemakers Market
        • 7.3.3.3.1 India Leadless Pacemakers Market, By Type
        • 7.3.3.3.2 India Leadless Pacemakers Market, By End-use
      • 7.3.3.4 South Korea Leadless Pacemakers Market
        • 7.3.3.4.1 South Korea Leadless Pacemakers Market, By Type
        • 7.3.3.4.2 South Korea Leadless Pacemakers Market, By End-use
      • 7.3.3.5 Singapore Leadless Pacemakers Market
        • 7.3.3.5.1 Singapore Leadless Pacemakers Market, By Type
        • 7.3.3.5.2 Singapore Leadless Pacemakers Market, By End-use
      • 7.3.3.6 Malaysia Leadless Pacemakers Market
        • 7.3.3.6.1 Malaysia Leadless Pacemakers Market, By Type
        • 7.3.3.6.2 Malaysia Leadless Pacemakers Market, By End-use
      • 7.3.3.7 Rest of Asia Pacific Leadless Pacemakers Market
        • 7.3.3.7.1 Rest of Asia Pacific Leadless Pacemakers Market, By Type
        • 7.3.3.7.2 Rest of Asia Pacific Leadless Pacemakers Market, By End-use
  • 7.4 LAMEA Leadless Pacemakers Market
    • 7.4.1 LAMEA Leadless Pacemakers Market, By Type
      • 7.4.1.1 LAMEA Micra Transcatheter Pacing System Market, By Country
      • 7.4.1.2 LAMEA Others Market, By Country
    • 7.4.2 LAMEA Leadless Pacemakers Market, By End-use
      • 7.4.2.1 LAMEA Hospitals Market, By Country
      • 7.4.2.2 LAMEA Outpatient Facilities Market, By Country
    • 7.4.3 LAMEA Leadless Pacemakers Market, By Country
      • 7.4.3.1 Brazil Leadless Pacemakers Market
        • 7.4.3.1.1 Brazil Leadless Pacemakers Market, By Type
        • 7.4.3.1.2 Brazil Leadless Pacemakers Market, By End-use
      • 7.4.3.2 Argentina Leadless Pacemakers Market
        • 7.4.3.2.1 Argentina Leadless Pacemakers Market, By Type
        • 7.4.3.2.2 Argentina Leadless Pacemakers Market, By End-use
      • 7.4.3.3 UAE Leadless Pacemakers Market
        • 7.4.3.3.1 UAE Leadless Pacemakers Market, By Type
        • 7.4.3.3.2 UAE Leadless Pacemakers Market, By End-use
      • 7.4.3.4 Saudi Arabia Leadless Pacemakers Market
        • 7.4.3.4.1 Saudi Arabia Leadless Pacemakers Market, By Type
        • 7.4.3.4.2 Saudi Arabia Leadless Pacemakers Market, By End-use
      • 7.4.3.5 South Africa Leadless Pacemakers Market
        • 7.4.3.5.1 South Africa Leadless Pacemakers Market, By Type
        • 7.4.3.5.2 South Africa Leadless Pacemakers Market, By End-use
      • 7.4.3.6 Nigeria Leadless Pacemakers Market
        • 7.4.3.6.1 Nigeria Leadless Pacemakers Market, By Type
        • 7.4.3.6.2 Nigeria Leadless Pacemakers Market, By End-use
      • 7.4.3.7 Rest of LAMEA Leadless Pacemakers Market
        • 7.4.3.7.1 Rest of LAMEA Leadless Pacemakers Market, By Type
        • 7.4.3.7.2 Rest of LAMEA Leadless Pacemakers Market, By End-use

Chapter 8. Company Profiles

  • 8.1 Medtronic PLC
    • 8.1.1 Company overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental and Regional Analysis
    • 8.1.4 Research & Development Expenses
    • 8.1.5 Recent strategies and developments:
      • 8.1.5.1 Partnerships, Collaborations, and Agreements:
      • 8.1.5.2 Product Launches and Product Expansions:
      • 8.1.5.3 Acquisition and Mergers:
      • 8.1.5.4 Geographical Expansions:
    • 8.1.6 SWOT Analysis
  • 8.2 Abbott Laboratories
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Segmental and Regional Analysis
    • 8.2.4 Research & Development Expense
    • 8.2.5 Recent strategies and developments:
      • 8.2.5.1 Product Launches and Product Expansions:
      • 8.2.5.2 Acquisition and Mergers:
    • 8.2.6 SWOT Analysis
  • 8.3 Boston Scientific Corporation
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Segmental and Regional Analysis
    • 8.3.4 Research & Development Expense
    • 8.3.5 Recent strategies and developments:
      • 8.3.5.1 Partnerships, Collaborations, and Agreements:
      • 8.3.5.2 Product Launches and Product Expansions:
      • 8.3.5.3 Acquisition and Mergers:
      • 8.3.5.4 Trials & Approval:
    • 8.3.6 SWOT Analysis
  • 8.4 Biotronik SE & Co. KG
    • 8.4.1 Company Overview
    • 8.4.2 Recent strategies and developments:
      • 8.4.2.1 Trials & Approval:
    • 8.4.3 SWOT Analysis
  • 8.5 Lepu Medical Technology Co., Ltd
    • 8.5.1 Company Overview
    • 8.5.2 SWOT Analysis
  • 8.6 Integer Holdings Corporation
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Segmental and Regional Analysis
    • 8.6.4 Research & Development Expenses
    • 8.6.5 SWOT Analysis
  • 8.7 MicroPort Scientific Corporation
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Segmental and Regional Analysis
    • 8.7.4 Research & Development Expense
    • 8.7.5 SWOT Analysis
  • 8.8 OSYPKA AG
    • 8.8.1 Company Overview
    • 8.8.2 SWOT Analysis
  • 8.9 Terumo Corporation
    • 8.9.1 Company Overview
    • 8.9.2 Financial Analysis
    • 8.9.3 Segmental and Regional Analysis
    • 8.9.4 Research & Development Expenses
    • 8.9.5 Recent strategies and developments:
      • 8.9.5.1 Partnerships, Collaborations, and Agreements:
      • 8.9.5.2 Acquisition and Mergers:
    • 8.9.6 SWOT Analysis
  • 8.10. EBR Systems, Inc.
    • 8.10.1 Company Overview
    • 8.10.2 SWOT Analysis

Chapter 9. Winning Imperatives of Leadless Pacemakers Market

LIST OF TABLES

  • TABLE 1 Global Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 2 Global Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 3 Partnerships, Collaborations and Agreements- Leadless Pacemakers Market
  • TABLE 4 Product Launches And Product Expansions- Leadless Pacemakers Market
  • TABLE 5 Acquisition and Mergers- Leadless Pacemakers Market
  • TABLE 6 Trials & Approvals- Leadless Pacemakers Market
  • TABLE 7 Global Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 8 Global Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 9 Global Micra Transcatheter Pacing System Market, By Region, 2019 - 2022, USD Thousands
  • TABLE 10 Global Micra Transcatheter Pacing System Market, By Region, 2023 - 2030, USD Thousands
  • TABLE 11 Global Others Market, By Region, 2019 - 2022, USD Thousands
  • TABLE 12 Global Others Market, By Region, 2023 - 2030, USD Thousands
  • TABLE 13 Global Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 14 Global Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 15 Global Hospitals Market, By Region, 2019 - 2022, USD Thousands
  • TABLE 16 Global Hospitals Market, By Region, 2023 - 2030, USD Thousands
  • TABLE 17 Global Outpatient Facilities Market, By Region, 2019 - 2022, USD Thousands
  • TABLE 18 Global Outpatient Facilities Market, By Region, 2023 - 2030, USD Thousands
  • TABLE 19 Global Leadless Pacemakers Market, By Region, 2019 - 2022, USD Thousands
  • TABLE 20 Global Leadless Pacemakers Market, By Region, 2023 - 2030, USD Thousands
  • TABLE 21 North America Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 22 North America Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 23 North America Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 24 North America Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 25 North America Micra Transcatheter Pacing System Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 26 North America Micra Transcatheter Pacing System Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 27 North America Others Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 28 North America Others Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 29 North America Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 30 North America Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 31 North America Hospitals Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 32 North America Hospitals Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 33 North America Outpatient Facilities Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 34 North America Outpatient Facilities Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 35 North America Leadless Pacemakers Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 36 North America Leadless Pacemakers Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 37 US Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 38 US Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 39 US Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 40 US Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 41 US Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 42 US Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 43 Canada Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 44 Canada Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 45 Canada Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 46 Canada Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 47 Canada Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 48 Canada Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 49 Mexico Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 50 Mexico Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 51 Mexico Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 52 Mexico Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 53 Mexico Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 54 Mexico Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 55 Rest of North America Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 56 Rest of North America Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 57 Rest of North America Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 58 Rest of North America Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 59 Rest of North America Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 60 Rest of North America Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 61 Europe Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 62 Europe Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 63 Europe Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 64 Europe Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 65 Europe Micra Transcatheter Pacing System Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 66 Europe Micra Transcatheter Pacing System Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 67 Europe Others Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 68 Europe Others Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 69 Europe Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 70 Europe Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 71 Europe Hospitals Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 72 Europe Hospitals Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 73 Europe Outpatient Facilities Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 74 Europe Outpatient Facilities Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 75 Europe Leadless Pacemakers Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 76 Europe Leadless Pacemakers Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 77 Germany Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 78 Germany Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 79 Germany Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 80 Germany Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 81 Germany Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 82 Germany Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 83 UK Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 84 UK Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 85 UK Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 86 UK Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 87 UK Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 88 UK Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 89 France Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 90 France Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 91 France Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 92 France Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 93 France Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 94 France Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 95 Russia Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 96 Russia Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 97 Russia Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 98 Russia Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 99 Russia Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 100 Russia Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 101 Spain Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 102 Spain Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 103 Spain Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 104 Spain Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 105 Spain Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 106 Spain Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 107 Italy Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 108 Italy Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 109 Italy Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 110 Italy Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 111 Italy Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 112 Italy Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 113 Rest of Europe Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 114 Rest of Europe Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 115 Rest of Europe Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 116 Rest of Europe Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 117 Rest of Europe Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 118 Rest of Europe Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 119 Asia Pacific Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 120 Asia Pacific Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 121 Asia Pacific Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 122 Asia Pacific Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 123 Asia Pacific Micra Transcatheter Pacing System Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 124 Asia Pacific Micra Transcatheter Pacing System Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 125 Asia Pacific Others Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 126 Asia Pacific Others Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 127 Asia Pacific Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 128 Asia Pacific Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 129 Asia Pacific Hospitals Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 130 Asia Pacific Hospitals Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 131 Asia Pacific Outpatient Facilities Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 132 Asia Pacific Outpatient Facilities Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 133 Asia Pacific Leadless Pacemakers Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 134 Asia Pacific Leadless Pacemakers Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 135 China Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 136 China Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 137 China Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 138 China Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 139 China Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 140 China Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 141 Japan Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 142 Japan Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 143 Japan Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 144 Japan Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 145 Japan Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 146 Japan Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 147 India Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 148 India Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 149 India Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 150 India Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 151 India Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 152 India Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 153 South Korea Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 154 South Korea Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 155 South Korea Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 156 South Korea Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 157 South Korea Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 158 South Korea Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 159 Singapore Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 160 Singapore Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 161 Singapore Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 162 Singapore Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 163 Singapore Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 164 Singapore Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 165 Malaysia Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 166 Malaysia Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 167 Malaysia Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 168 Malaysia Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 169 Malaysia Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 170 Malaysia Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 171 Rest of Asia Pacific Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 172 Rest of Asia Pacific Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 173 Rest of Asia Pacific Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 174 Rest of Asia Pacific Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 175 Rest of Asia Pacific Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 176 Rest of Asia Pacific Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 177 LAMEA Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 178 LAMEA Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 179 LAMEA Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 180 LAMEA Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 181 LAMEA Micra Transcatheter Pacing System Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 182 LAMEA Micra Transcatheter Pacing System Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 183 LAMEA Others Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 184 LAMEA Others Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 185 LAMEA Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 186 LAMEA Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 187 LAMEA Hospitals Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 188 LAMEA Hospitals Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 189 LAMEA Outpatient Facilities Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 190 LAMEA Outpatient Facilities Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 191 LAMEA Leadless Pacemakers Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 192 LAMEA Leadless Pacemakers Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 193 Brazil Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 194 Brazil Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 195 Brazil Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 196 Brazil Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 197 Brazil Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 198 Brazil Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 199 Argentina Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 200 Argentina Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 201 Argentina Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 202 Argentina Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 203 Argentina Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 204 Argentina Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 205 UAE Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 206 UAE Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 207 UAE Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 208 UAE Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 209 UAE Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 210 UAE Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 211 Saudi Arabia Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 212 Saudi Arabia Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 213 Saudi Arabia Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 214 Saudi Arabia Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 215 Saudi Arabia Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 216 Saudi Arabia Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 217 South Africa Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 218 South Africa Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 219 South Africa Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 220 South Africa Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 221 South Africa Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 222 South Africa Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 223 Nigeria Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 224 Nigeria Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 225 Nigeria Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 226 Nigeria Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 227 Nigeria Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 228 Nigeria Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 229 Rest of LAMEA Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 230 Rest of LAMEA Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 231 Rest of LAMEA Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 232 Rest of LAMEA Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 233 Rest of LAMEA Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 234 Rest of LAMEA Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 235 Key Information - Medtronic PLC
  • TABLE 236 Key Information - Abbott Laboratories
  • TABLE 237 Key Information - Boston Scientific Corporation
  • TABLE 238 Key Information - Biotronik SE & Co. KG
  • TABLE 239 Key Information - Lepu Medical Technology Co., Ltd
  • TABLE 240 Key Information - Integer Holdings Corporation
  • TABLE 241 key Information - MicroPort Scientific Corporation
  • TABLE 242 Key Information - OSYPKA AG
  • TABLE 243 Key Information - Terumo Corporation
  • TABLE 244 Key Information - EBR Systems, Inc.